Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav Goyal

Showing results (141-150 of 186) with videos related to

Pageof 19
Sort By:
Mayo Clinic Proceedings|September 2, 2019
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman DiseaseGaurav Goyal, Jason R Young, Matthew J Koster, et al.
The Oncologist|May 31, 2022
Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experienceGaurav Goyal, Jason R Young, Jithma P Abeykoon, et al.
Leukemia & Lymphoma|July 26, 2023
Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimenSydney Dunn-Valadez, Srilakshmi Bathini, Kathleen E Purdy, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 9, 2025
Burden of Chronic Health Conditions Among People With HIV and Common Non-AIDS-Defining CancersGaurav Goyal, Ene M Enogela, Greer A Burkholder, et al.
British Journal of Haematology|February 18, 2026
Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challengeVyshnavi Rallapalle, Sailesh I S Kumar, Brinda Shukla, et al.
Leukemia|April 15, 2018
Treatment approaches and outcomes in plasmacytomas: analysis using a national datasetGaurav Goyal, Adam C Bartley, Shealeigh Funni, et al.
Haematologica|December 22, 2022
Patient-reported fatigue and pain in Erdheim-Chester disease: a registry-based, mixed methods studyAnne S Reiner, Dana Bossert, Justin J Buthorn, et al.
Current Neurology and Neuroscience Reports|May 20, 2023
Neurological Manifestations of Histiocytic DisordersSamantha A Banks, Julio C Sartori Valinotti, Ronald S Go, et al.
British Journal of Haematology|August 26, 2022
Classical and non-classical phenotypes of Erdheim-Chester disease: Correlating clinical, radiographic and genotypic findingsAntonious Z Hazim, Aldo A Acosta-Medina, Jason R Young, et al.
Leukemia|February 11, 2025
Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variantsAldo A Acosta-Medina, Jithma P Abeykoon, Saurabh Zanwar, et al.
Pageof 19

Showing results (141-150 of 186) with videos related to

Sort By:
Pageof 19
Mayo Clinic Proceedings|September 2, 2019
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman DiseaseGaurav Goyal, Jason R Young, Matthew J Koster, et al.
The Oncologist|May 31, 2022
Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experienceGaurav Goyal, Jason R Young, Jithma P Abeykoon, et al.
Leukemia & Lymphoma|July 26, 2023
Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimenSydney Dunn-Valadez, Srilakshmi Bathini, Kathleen E Purdy, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 9, 2025
Burden of Chronic Health Conditions Among People With HIV and Common Non-AIDS-Defining CancersGaurav Goyal, Ene M Enogela, Greer A Burkholder, et al.
British Journal of Haematology|February 18, 2026
Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challengeVyshnavi Rallapalle, Sailesh I S Kumar, Brinda Shukla, et al.
Leukemia|April 15, 2018
Treatment approaches and outcomes in plasmacytomas: analysis using a national datasetGaurav Goyal, Adam C Bartley, Shealeigh Funni, et al.
Haematologica|December 22, 2022
Patient-reported fatigue and pain in Erdheim-Chester disease: a registry-based, mixed methods studyAnne S Reiner, Dana Bossert, Justin J Buthorn, et al.
Current Neurology and Neuroscience Reports|May 20, 2023
Neurological Manifestations of Histiocytic DisordersSamantha A Banks, Julio C Sartori Valinotti, Ronald S Go, et al.
British Journal of Haematology|August 26, 2022
Classical and non-classical phenotypes of Erdheim-Chester disease: Correlating clinical, radiographic and genotypic findingsAntonious Z Hazim, Aldo A Acosta-Medina, Jason R Young, et al.
Leukemia|February 11, 2025
Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variantsAldo A Acosta-Medina, Jithma P Abeykoon, Saurabh Zanwar, et al.
Pageof 19